Focus Groups to Determine Surrogates Views Regarding Patient Preference Predictors

Normal Physiology Clinical Trial

Official title:

Focus Groups to Determine Surrogates' Views Regarding Patient Preference Predictors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02898194
• Other study ID #: 160168
• Secondary ID: 16-CC-0168
• Status: Completed
• Start date: December 31, 2018
• Est. completion date: July 21, 2020

Study information

• Verified date: November 13, 2023
• Source: National Institutes of Health Clinical Center (CC)
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Background:

Some people cannot make medical treatment decisions on their own. The people who make decisions on their behalf are called medical surrogates. Sometimes surrogates cannot predict which treatment course the person or their loved ones would have chosen. The surrogates often become distressed because of making these decisions. Researchers think a tool called a Patient Preference Predictor (PPP) may be able to make the process easier. The PPP would predict what treatment the person would want. This is based on treatment preferences of similar people in a similar circumstance. Researchers want to interview surrogates to explore their views on the PPP.

Objective:

To explore surrogates views on incorporating a PPP into shared medical decision-making.

Eligibility:

People 18 years or older who:

Have acted as a surrogate medical decision-maker within the past 3 years. This includes decisions about

treatment, medication, hospice care, hospital admission, or discharge.

Are not pregnant

Design:

Participants will be screened by meeting with clinicians in person or by phone to discuss the study.

Participants will take part in a focus group. This is a small group of people discussing their thoughts and opinions. This will last for about 2 hours.

Participants will be served a light meal.

Participants will provide information about themselves and their views. They will talk about their past experiences making medical decisions for someone. They will discuss how they felt about these decisions.

The PPP will be explained to participants. They will give their views on it.

The research team will audio record the focus group and take notes.

Participants will fill out questionnaires.

Description:

Current clinical practice relies on shared decision-making between clinicians and surrogates to make treatment decisions for patients who cannot decide on their own. This decision-making process is meant to promote medical care that accords with the patient s own preferences and values. However, empirical data suggest that this model faces two significant challenges. First, both surrogates and clinicians have trouble predicting which treatment course patients would have chosen. Second, given the nature of the decisions, surrogates often experience significant emotional distress as a result of making treatment decisions. To address these concerns it has been suggested that the shared decision-making process might be supplemented with a Patient Preference Predictor (PPP). A PPP would provide a prediction of which treatment a given patient would want based on the treatment preferences of similar patients in similar circumstances. The present study proposes to interview surrogates who have been involved in making decisions for an incapacitated patient to explore their perspectives on the PPP and how to incorporate it into medical decision-making for incapacitated patients..

Recruitment information / eligibility

• Status: Completed
• Enrollment: 27
• Est. completion date: July 21, 2020
• Est. primary completion date: February 20, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

• INCLUSION CRITERIA:

• 18 years or older

• Experience making at least one medical decision on behalf of an incompetent patient within the past 3 years. A medical decision for the purposes of this study is defined as making a decision in a context in which there was more than 1 feasible or reasonable option.

• Ability to provide informed consent

EXCLUSION CRITERIA:

• Inability to speak, understand, or read English

• The patient on behalf of whom the individual acted as surrogate is deceased for less than two months.

• In the view of the referring clinician, participation in the study is deemed excessively burdensome.

• Candidate for study is pregnant

• Court appointed surrogate

Related Conditions & MeSH terms

• Normal Physiology

Locations

Country	Name	City	State
United States	National Institutes of Health Clinical Center	Bethesda	Maryland
United States	St. Elizabeths Hospital	Washington	District of Columbia

Sponsors (1)

Lead Sponsor	Collaborator
National Institutes of Health Clinical Center (CC)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Rid A, Wendler D. Use of a patient preference predictor to help make medical decisions for incapacitated patients. J Med Philos. 2014 Apr;39(2):104-29. doi: 10.1093/jmp/jhu001. Epub 2014 Feb 13. — View Citation

Rid A, Wesley R, Pavlick M, Maynard S, Roth K, Wendler D. Patients' priorities for treatment decision making during periods of incapacity: quantitative survey. Palliat Support Care. 2015 Oct;13(5):1165-83. doi: 10.1017/S1478951514001096. Epub 2014 Oct 2. — View Citation

Shalowitz DI, Garrett-Mayer E, Wendler D. How should treatment decisions be made for incapacitated patients, and why? PLoS Med. 2007 Mar;4(3):e35. doi: 10.1371/journal.pmed.0040035. No abstract available. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Views of participants on PPP	Level of acceptance regarding Patient Preference Predictor (PPP)	Prior to, during, and immediately following the focus group session
Secondary	Views of Participants on PPP as patients	Level of acceptance regarding PPP	Prior to, during, and immediately following the focus group

External Links

•   NIH Clinical Center Detailed Web Page